DRKS00010675Not yet recruitingNot Applicable
Expression of programmed cell death-1 (PD-1) and its ligand PD-L1 and PD-L2 as well as the enzyme indolamin 2,3-dioxygenase (IDO) in primary lymphomas of the skin
niversitätsklinik FreiburgDermatologie und Venerologie0 sites40 target enrollmentStarted: June 30, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- one to one (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 1
Programmed cell death ligand 1 expression and clinical correlation in epithelial ovarian carcinoma patientsEpithelial Ovarian Carcinoma patientsOvary,Carcinoma,Prognosis,PDL1TCTR20161115004Siriraj Research Development Fund92
Unknown
Not Applicable
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control StudyLichen PlanusNCT04892381Cairo University60
Unknown
Not Applicable
PD-L1 Expression in Advanced OsteosarcomaProgressionSurvivalNCT03582527Peking University People's Hospital50
Unknown
Not Applicable
The Predictive Role of Programmed Death Ligand 1 (PD-L1) and Neutrophil to Lymphocyte Ratio (NLR) in Non-Small Cell Lung Cancer (NSCLC)To Define an Easy and Feasible Panel Which May be Routinely Applied to Select Patients for Immunotherapy Avoiding More Complex and Expensive MethodsNCT03816657Fondazione Ricerca Traslazionale93
Not yet recruiting
Not Applicable
correlation between blood levels of immune co-inhibitory molecules disease severity and treatment response in alopecia areata patientsCTRI/2021/03/032196Post Graduate Institute of Medical Education and Research Chandigarh